Role of 18F-FDG PET/CT in the Carcinoma of the Uterus: A Review of Literature.
10.3349/ymj.2014.55.6.1467
- Author:
Alessandra MUSTO
1
;
Gaia GRASSETTO
;
Maria Cristina MARZOLA
;
Sotirios CHONDROGIANNIS
;
Anna Margherita MAFFIONE
;
Lucia RAMPIN
;
David FUSTER
;
Francesco GIAMMARILE
;
Patrick M COLLETTI
;
Domenico RUBELLO
Author Information
1. Nuclear Medicine Service, Ospedale Maggiore, Bologna, Italy.
- Publication Type:Review
- Keywords:
Uterine cancer;
cervical cancer;
FDG PET/CT;
contrast enhanced CT;
MRI;
accuracy;
predictive value;
prognosis
- MeSH:
Carcinoma/*pathology;
Female;
Fluorodeoxyglucose F18/*diagnostic use;
Humans;
*Magnetic Resonance Imaging;
Neoplasm Staging;
Positron-Emission Tomography/*methods;
Predictive Value of Tests;
Sensitivity and Specificity;
Tomography, X-Ray Computed/*methods;
Uterine Neoplasms/*pathology;
Uterus
- From:Yonsei Medical Journal
2014;55(6):1467-1472
- CountryRepublic of Korea
- Language:English
-
Abstract:
In the present review we reported the value of 18F-fluorodeoxyglucose (FDG) PET/CT in face of uterine cancer, in terms of sensitivity, specificity and accuracy. Moreover, we made a comparison with the other imaging techniques currently used to evacuate these tumors including contrast-enhanced CT, contrast enhanced-MRI and transvaginal ultrasonography. FDG PET/CT has been reported to be of particular value in detecting occult metastatic lesions, in prediction of response to treatment and as a pro-gnostic factor.
